A citation-based method for searching scientific literature

Kenji Maeda, Masayuki Amano, Yukari Uemura, Kiyoto Tsuchiya, Tomoko Matsushima, Kenta Noda, Yosuke Shimizu, Asuka Fujiwara, Yuki Takamatsu, Yasuko Ichikawa, Hidehiro Nishimura, Mari Kinoshita, Shota Matsumoto, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Shin-Ichi Oka, Ayako Mikami, Wataru Sugiura, Toshiyuki Sato, Tomokazu Yoshida, Shinya Shimada, Hiroaki Mitsuya. Sci Rep 2021
Times Cited: 28







List of co-cited articles
67 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
46

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert, Stephen A Spector, Nadine Rouphael, C Buddy Creech,[...]. N Engl J Med 2021
28

Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers.
Si'Ana A Coggins, Eric D Laing, Cara H Olsen, Emilie Goguet, Matthew Moser, Belinda M Jackson-Thompson, Emily C Samuels, Simon D Pollett, David R Tribble, Julian Davies,[...]. Open Forum Infect Dis 2021
17
41

Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals.
Kenji Maeda, Masayuki Amano, Yukari Uemura, Kiyoto Tsuchiya, Tomoko Matsushima, Kenta Noda, Yosuke Shimizu, Asuka Fujiwara, Yuki Takamatsu, Yasuko Ichikawa,[...]. medRxiv 2021
7
85

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.
Kenji Maeda, Nobuyo Higashi-Kuwata, Noriko Kinoshita, Satoshi Kutsuna, Kiyoto Tsuchiya, Shin-Ichiro Hattori, Kouki Matsuda, Yuki Takamatsu, Hiroyuki Gatanaga, Shinichi Oka,[...]. Sci Rep 2021
21
28

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
Einav G Levin, Yaniv Lustig, Carmit Cohen, Ronen Fluss, Victoria Indenbaum, Sharon Amit, Ram Doolman, Keren Asraf, Ella Mendelson, Arnona Ziv,[...]. N Engl J Med 2021
539
17

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Edward E Walsh, Robert W Frenck, Ann R Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J Mulligan, Ruth Bailey,[...]. N Engl J Med 2020
17

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
Delphine Planas, David Veyer, Artem Baidaliuk, Isabelle Staropoli, Florence Guivel-Benhassine, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Nicolas Robillard, Julien Puech,[...]. Nature 2021
14

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
Moriah Bergwerk, Tal Gonen, Yaniv Lustig, Sharon Amit, Marc Lipsitch, Carmit Cohen, Michal Mandelboim, Einav Gal Levin, Carmit Rubin, Victoria Indenbaum,[...]. N Engl J Med 2021
577
14

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Xinxue Liu, Robert H Shaw, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews, J Claire Cameron, Sue Charlton, Elizabeth A Clutterbuck, Andrea M Collins,[...]. Lancet 2021
205
14

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.
Joseph E Ebinger, Justyna Fert-Bober, Ignat Printsev, Min Wu, Nancy Sun, John C Prostko, Edwin C Frias, James L Stewart, Jennifer E Van Eyk, Jonathan G Braun,[...]. Nat Med 2021
311
14

Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study.
Paul Naaber, Liina Tserel, Kadri Kangro, Epp Sepp, Virge Jürjenson, Ainika Adamson, Liis Haljasmägi, Anna Pauliina Rumm, Regina Maruste, Jaanika Kärner,[...]. Lancet Reg Health Eur 2021
234
14

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
Noa Dagan, Noam Barda, Eldad Kepten, Oren Miron, Shay Perchik, Mark A Katz, Miguel A Hernán, Marc Lipsitch, Ben Reis, Ran D Balicer. N Engl J Med 2021
14

Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan.
Takahiro Kageyama, Kei Ikeda, Shigeru Tanaka, Toshibumi Taniguchi, Hidetoshi Igari, Yoshihiro Onouchi, Atsushi Kaneda, Kazuyuki Matsushita, Hideki Hanaoka, Taka-Aki Nakada,[...]. Clin Microbiol Infect 2021
52
14

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Ugur Sahin, Alexander Muik, Isabel Vogler, Evelyna Derhovanessian, Lena M Kranz, Mathias Vormehr, Jasmin Quandt, Nicole Bidmon, Alexander Ulges, Alina Baum,[...]. Nature 2021
266
14

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.
Cristina Menni, Kerstin Klaser, Anna May, Lorenzo Polidori, Joan Capdevila, Panayiotis Louca, Carole H Sudre, Long H Nguyen, David A Drew, Jordi Merino,[...]. Lancet Infect Dis 2021
349
14

Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination.
Lisa Müller, Marcel Andrée, Wiebke Moskorz, Ingo Drexler, Lara Walotka, Ramona Grothmann, Johannes Ptok, Jonas Hillebrandt, Anastasia Ritchie, Denise Rabl,[...]. Clin Infect Dis 2021
226
14

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
Florian Krammer, Komal Srivastava, Hala Alshammary, Angela A Amoako, Mahmoud H Awawda, Katherine F Beach, Maria C Bermúdez-González, Dominika A Bielak, Juan M Carreño, Rachel L Chernet,[...]. N Engl J Med 2021
415
10

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.
Shuo Feng, Daniel J Phillips, Thomas White, Homesh Sayal, Parvinder K Aley, Sagida Bibi, Christina Dold, Michelle Fuskova, Sarah C Gilbert, Ian Hirsch,[...]. Nat Med 2021
382
10

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.
Pinja Jalkanen, Pekka Kolehmainen, Hanni K Häkkinen, Moona Huttunen, Paula A Tähtinen, Rickard Lundberg, Sari Maljanen, Arttu Reinholm, Sisko Tauriainen, Sari H Pakkanen,[...]. Nat Commun 2021
130
10

Antibody titres decline 3-month post-vaccination with BNT162b2.
Julien Favresse, Jean-Louis Bayart, François Mullier, Marc Elsen, Christine Eucher, Sandrine Van Eeckhoudt, Tatiana Roy, Gregoire Wieers, Christine Laurent, Jean-Michel Dogné,[...]. Emerg Microbes Infect 2021
86
10

Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.
Evangelos Terpos, Ioannis P Trougakos, Filia Apostolakou, Ioanna Charitaki, Aimilia D Sklirou, Nefeli Mavrianou, Eleni-Dimitra Papanagnou, Christine-Ivy Liacos, Sentiljana Gumeni, Gianna Rentziou,[...]. Am J Hematol 2021
88
10

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Peter B Gilbert, David C Montefiori, Adrian B McDermott, Youyi Fong, David Benkeser, Weiping Deng, Honghong Zhou, Christopher R Houchens, Karen Martins, Lakshmi Jayashankar,[...]. Science 2022
285
10

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
Nicole Doria-Rose, Mehul S Suthar, Mat Makowski, Sarah O'Connell, Adrian B McDermott, Britta Flach, Julie E Ledgerwood, John R Mascola, Barney S Graham, Bob C Lin,[...]. N Engl J Med 2021
354
10

Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?
Masaaki Takeuchi, Yukie Higa, Akina Esaki, Yosuke Nabeshima, Akemi Nakazono. PLoS One 2021
11
27

Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
Shohei Yamamoto, Ami Fukunaga, Akihito Tanaka, Junko S Takeuchi, Yosuke Inoue, Moto Kimura, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie,[...]. Vaccine 2022
7
42

A new coronavirus associated with human respiratory disease in China.
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhi-Gang Song, Yi Hu, Zhao-Wu Tao, Jun-Hua Tian, Yuan-Yuan Pei,[...]. Nature 2020
10

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study.
David Hillus, Tatjana Schwarz, Pinkus Tober-Lau, Kanika Vanshylla, Hana Hastor, Charlotte Thibeault, Stefanie Jentzsch, Elisa T Helbig, Lena J Lippert, Patricia Tscheak,[...]. Lancet Respir Med 2021
138
10

A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies.
Kenta Noda, Kouki Matsuda, Shigehiro Yagishita, Kenji Maeda, Yutaro Akiyama, Junko Terada-Hirashima, Hiromichi Matsushita, Satoshi Iwata, Kazuto Yamashita, Yusuke Atarashi,[...]. Sci Rep 2021
27
11

SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine.
Kayoko Hayakawa, Satoshi Kutsuna, Takeo Kawamata, Yuko Sugiki, Chiharu Nonaka, Keiko Tanaka, Michi Shoji, Masaki Nagai, Shunsuke Tezuka, Kazuyuki Shinya,[...]. Glob Health Med 2020
16
12

Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups.
Madhusudhanan Narasimhan, Lenin Mahimainathan, Ellen Araj, Andrew E Clark, John Markantonis, Allen Green, Jing Xu, Jeffrey A SoRelle, Charles Alexis, Kimberly Fankhauser,[...]. J Clin Microbiol 2021
52
7

Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.
Ashley Fowlkes, Manjusha Gaglani, Kimberly Groover, Matthew S Thiese, Harmony Tyner, Katherine Ellingson. MMWR Morb Mortal Wkly Rep 2021
138
7

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
Sara Y Tartof, Jeff M Slezak, Heidi Fischer, Vennis Hong, Bradley K Ackerson, Omesh N Ranasinghe, Timothy B Frankland, Oluwaseye A Ogun, Joann M Zamparo, Sharon Gray,[...]. Lancet 2021
436
7

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
Chang Liu, Helen M Ginn, Wanwisa Dejnirattisai, Piyada Supasa, Beibei Wang, Aekkachai Tuekprakhon, Rungtiwa Nutalai, Daming Zhou, Alexander J Mentzer, Yuguang Zhao,[...]. Cell 2021
371
7

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, Rodney Daniels, Philip Hobson, Emine Hatipoglu, Yenting Ngai,[...]. Lancet 2021
286
7

Neutralizing monoclonal antibodies for treatment of COVID-19.
Peter C Taylor, Andrew C Adams, Matthew M Hufford, Inmaculada de la Torre, Kevin Winthrop, Robert L Gottlieb. Nat Rev Immunol 2021
263
7

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Eileen Gallagher, Ruth Simmons, Simon Thelwall, Julia Stowe, Elise Tessier, Natalie Groves, Gavin Dabrera,[...]. N Engl J Med 2021
7

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Jerald Sadoff, Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn, Paul A Goepfert, Carla Truyers, Hein Fennema, Bart Spiessens,[...]. N Engl J Med 2021
7

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
7


Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
David S Khoury, Deborah Cromer, Arnold Reynaldi, Timothy E Schlub, Adam K Wheatley, Jennifer A Juno, Kanta Subbarao, Stephen J Kent, James A Triccas, Miles P Davenport. Nat Med 2021
7

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.
Koen B Pouwels, Emma Pritchard, Philippa C Matthews, Nicole Stoesser, David W Eyre, Karina-Doris Vihta, Thomas House, Jodie Hay, John I Bell, John N Newton,[...]. Nat Med 2021
219
7

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, Brian Angus, Vicky L Baillie, Shaun L Barnabas, Qasim E Bhorat,[...]. Lancet 2021
7

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Hongchao Pan, Richard Peto, Ana-Maria Henao-Restrepo, Marie-Pierre Preziosi, Vasee Sathiyamoorthy, Quarraisha Abdool Karim, Marissa M Alejandria, César Hernández García, Marie-Paule Kieny, Reza Malekzadeh,[...]. N Engl J Med 2021
7

How we secured a COVID-19 convalescent plasma procurement scheme in Japan.
Mari Terada, Satoshi Kutsuna, Tomiteru Togano, Sho Saito, Noriko Kinoshita, Yumiko Shimanishi, Tetsuya Suzuki, Yusuke Miyazato, Makoto Inada, Takahito Nakamoto,[...]. Transfusion 2021
7
28

Occurrence of BNT162b2 Vaccine Adverse Reactions Is Associated with Enhanced SARS-CoV-2 IgG Antibody Response.
Yoav Rechavi, Moshe Shashar, Jonathan Lellouche, Moshe Yana, Daniel Yakubovich, Nechama Sharon. Vaccines (Basel) 2021
7
28

Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers.
Amanda K Debes, Shaoming Xiao, Elizabeth Colantuoni, Emily R Egbert, Patrizio Caturegli, Avinash Gadala, Aaron M Milstone. JAMA Intern Med 2021
17
11

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Ugur Sahin, Alexander Muik, Evelyna Derhovanessian, Isabel Vogler, Lena M Kranz, Mathias Vormehr, Alina Baum, Kristen Pascal, Jasmin Quandt, Daniel Maurus,[...]. Nature 2020
902
7

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.
Rishi R Goel, Sokratis A Apostolidis, Mark M Painter, Divij Mathew, Ajinkya Pattekar, Oliva Kuthuru, Sigrid Gouma, Philip Hicks, Wenzhao Meng, Aaron M Rosenfeld,[...]. Sci Immunol 2021
279
7

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
Noam Barda, Noa Dagan, Yatir Ben-Shlomo, Eldad Kepten, Jacob Waxman, Reut Ohana, Miguel A Hernán, Marc Lipsitch, Isaac Kohane, Doron Netzer,[...]. N Engl J Med 2021
325
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.